Lantheus Holdings, Inc

LNTH XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Cap

6.3B

Short interest (May 15)

9.9%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.37%

↑ 3.6%

Available Shares

1M

↑ 67.3%

Price Chart

Company Overview

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Company Info

Exchange: NASDAQ
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CIK: 0001521036
Asset Type: CS

Market Data

Market Cap: $6,269,715,696
Employees: 1,193
Status: Active

Short Interest

Current Borrow Fee 0.37%
Range: 0.37% - 0.37%
Available Shares 1M
Range: 1.4M - 1.4M

Recent Changes

Fee Change: ↑ 0.4%
Available Change: ↑ 92.6%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime